Author： Mabuchi Hiroshi Nohara Atsushi
Publisher： Future Medicine
ISSN： 1758-4299
Source： Clinical Lipidology, Vol.8, Iss.4, 2013-08, pp. : 387-389
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Economic Impact of Treating Inhibitor Patients
Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. :
Access to resources
Recommend
Inhibitor development and mortality in non‐severe hemophilia A
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 7, 2015-07 ,pp. :
A large‐scale computational study of inhibitor risk in non‐severe haemophilia A
BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 3, 2015-02 ,pp. :
New associations: INFG and TGFB1 genes and the inhibitor development in severe haemophilia A
HAEMOPHILIA, Vol. 21, Iss. 4, 2015-07 ,pp. :